Colonisation and infection with resistant gram-positive cocci - Epidemiology and risk factors

被引:17
作者
Cars, O [1 ]
机构
[1] Univ Uppsala Hosp, Dept Infect Dis, S-75185 Uppsala, Sweden
关键词
D O I
10.2165/00003495-199700546-00004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Only a few years after the introduction of penicillin, resistant staphylococci were isolated in hospitals. This situation has led to the development of semisynthetic penicillins. Today, multiresistant Gram-positive bacteria have become an increasing problem in both hospitals and the community, frequently leaving the glycopeptides as the only therapeutic option. Notable problem pathogens are methicillin-resistant Staphylococcus aureus, coagulase-negative staphylococci and glycopeptide-resistant enterococci in the nosocomial environment, and penicillin-resistant Streptococcus pneumoniae in the community. In the hospital setting, as well as in the community and in animal husbandry, crowding and poor hygiene can facilitate the spread of resistant bacteria selected by antibiotic usage. However, the precise epidemiology and frequency of each drug-resistant pathogen depends on geographical location, the patient group involved and previous antibiotic use. Active measures need to be taken to reduce the spread of these pathogens and thus preserve the efficacy of available antibiotics.
引用
收藏
页码:4 / 10
页数:7
相关论文
共 42 条
  • [11] CHARACTERIZATION OF GLYCOPEPTIDE-RESISTANT ENTEROCOCCI FROM UNITED-STATES HOSPITALS
    CLARK, NC
    COOKSEY, RC
    HILL, BC
    SWENSON, JM
    TENOVER, FC
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (11) : 2311 - 2317
  • [12] Emerging resistance to antimicrobial agents in gram-positive bacteria - Enterococci, staphylococci and nonpneumococcal streptococci
    Cormican, MG
    Jones, RN
    [J]. DRUGS, 1996, 51 : 6 - 12
  • [13] EPIDEMIC METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS - CONTROLLING THE SPREAD OUTSIDE HOSPITAL
    COX, RA
    MALLAGHAN, C
    CONQUEST, C
    KING, J
    [J]. JOURNAL OF HOSPITAL INFECTION, 1995, 29 (02) : 107 - 119
  • [14] DASCHNER FD, 1995, EUR J CLIN MICROBIOL, V14, pS12
  • [15] DOEBBELING BN, 1995, J CHEMOTHERAPY, V7, P99
  • [16] VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM BACTEREMIA - RISK-FACTORS FOR INFECTION
    EDMOND, MB
    OBER, JF
    WEINBAUM, DL
    PFALLER, MA
    HWANG, T
    SANFORD, MD
    WENZEL, RP
    [J]. CLINICAL INFECTIOUS DISEASES, 1995, 20 (05) : 1126 - 1133
  • [17] ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - AN EPIDEMIOLOGIC SURVEY IN FRANCE, 1970-1990
    GESLIN, P
    BUUHOI, A
    FREMAUX, A
    ACAR, JF
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) : 95 - 98
  • [18] Vancomycin-resistant enterococci
    Gin, AS
    Zhanel, GG
    [J]. ANNALS OF PHARMACOTHERAPY, 1996, 30 (06) : 615 - 624
  • [19] RESISTANCE TO CEFTRIAXONE AND OTHER BETA-LACTAMS IN BACTERIA ISOLATED IN THE COMMUNITY
    GOLDSTEIN, FW
    PEAN, Y
    GERTNER, J
    SCAVINER, P
    DESHAYESLARTIGUE, L
    MOUSSION, J
    MOUSSION, J
    CORTEEL, P
    GRELAT, S
    SARZIER, JM
    LEPARGNEUR, JP
    MASSON, P
    PICARD, P
    KUNZELMANN, JM
    MASSOUBRE, B
    NAPOLY, V
    FERMON, I
    LEFEBVRE, E
    MOUNARD, JL
    GOJON, U
    BLANCHON, P
    MASSET, J
    MURAINE, J
    GRIGNON, JC
    VIARDGAUDIN, R
    FORESTIER, G
    GERMAIN, X
    LAUDAT, P
    SCHUH, V
    CHRISTOPHE, AM
    BALMAYER, B
    SESTILANGE, J
    LAHIANI, F
    VALENTIN, JC
    BERT, JY
    DIESNIS, P
    FLORANGE, P
    BROSSET, C
    NAHMANI, A
    QUERCIA, C
    FRANCAIS, JL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) : 2516 - 2519
  • [20] ERADICATION OF ENDEMIC METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS INFECTIONS FROM A NEONATAL INTENSIVE-CARE UNIT
    HALEY, RW
    CUSHION, NB
    TENOVER, FC
    BANNERMAN, TL
    DRYER, D
    ROSS, J
    SANCHEZ, PJ
    SIEGEL, JD
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 171 (03) : 614 - 624